|Bid||3.56 x 100|
|Ask||4.50 x 1000|
|Day's Range||3.91 - 4.13|
|52 Week Range||2.41 - 6.44|
|PE Ratio (TTM)||-0.91|
|Earnings Date||Nov 15, 2017 - Nov 20, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||2.00|
Research Desk Line-up: Cesca Therapeutics Post Earnings Coverage LONDON, UK / ACCESSWIRE / October 9, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for ...
NEW YORK, NY / ACCESSWIRE / October 4, 2017 / Celsion's shares soared to skyrocket levels on Tuesday after revealing final clinical and translational data from its OVATION study. Shares of Cesca Therapeutics ...
RANCHO CORDOVA, Calif., Oct. 03, 2017-- Cesca Therapeutics Inc., a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced that the U.S. Patent and ...